These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33940597)

  • 21. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose aspirin does not lower in vivo platelet activation in healthy smokers.
    Pernerstorfer T; Stohlawetz P; Stummvoll G; Kapiotis S; Szekeres T; Eichler HG; Jilma B
    Br J Haematol; 1998 Sep; 102(5):1229-31. PubMed ID: 9753050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
    Santilli F; Lapenna D; La Barba S; Davì G
    Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
    Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y
    J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
    Lippi G; Franchini M; Targher G
    Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.
    Wang W; Yang L; Song L; Guo M; Li C; Yang B; Wang M; Kou N; Gao J; Qu H; Ma Y; Xue M; Shi D
    Biomed Pharmacother; 2021 Feb; 134():111165. PubMed ID: 33370633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of antiplatelet agents in sepsis: a glimpse into the future.
    Akinosoglou K; Alexopoulos D
    Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Platelet Lifeline to Cancer: Challenges and Opportunities.
    Haemmerle M; Stone RL; Menter DG; Afshar-Kharghan V; Sood AK
    Cancer Cell; 2018 Jun; 33(6):965-983. PubMed ID: 29657130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.
    Serebruany VL; Midei MG; Meilman H; Malinin AI; Lowry DR
    Int J Clin Pract; 2006 Jul; 60(7):863-6. PubMed ID: 16846403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring.
    Harrison P
    Thromb Res; 2010 Aug; 126(2):e137-8. PubMed ID: 19931889
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet-targeted pharmacologic treatments as anti-cancer therapy.
    Gresele P; Momi S; Malvestiti M; Sebastiano M
    Cancer Metastasis Rev; 2017 Jun; 36(2):331-355. PubMed ID: 28707198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
    Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.
    Dai H; Chen J; Tao Q; Zhu J; Zhang F; Zheng L; Qiu Y
    Postgrad Med J; 2003 Sep; 79(935):522-6. PubMed ID: 13679549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
    Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
    Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
    Natarajan A; Zaman AG; Marshall SM
    Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study.
    Mikami J; Kurokawa Y; Takahashi T; Miyazaki Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gastric Cancer; 2016 Jul; 19(3):817-26. PubMed ID: 26486505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.
    Blair TA; Moore SF; Hers I
    J Thromb Haemost; 2015 Aug; 13(8):1479-93. PubMed ID: 26039631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet Apoptotic Response May Be Associated With the Capacity of Aspirin to Inhibit Platelets.
    Zamorano-León JJ; Gascón M; Martínez CH; Freixer G; Guerra R; Zekri-Nechar K; Bernardo E; Serna-Soto M; Segura A; Giner M; García-Fernández MA; Macaya C; López-Farré AJ
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):584-591. PubMed ID: 33170592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia.
    Clavijo LC; Al-Asady N; Dhillon A; Matthews RV; Caro J; Tun H; Rowe V; Shavelle DM
    Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):516-520. PubMed ID: 29221961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.